Communiqués Phase Holographic Imaging PHI AB

Actions

Cours en clôture NORDIC GROWTH MARKET Autres places de cotation 00:00:00 31/01/2024			Varia. 5j.	Varia. 1 janv.
6,46 ^SEK	-4,44%		-.--%	+8,39%

27/03	Phase Holographic Imaging PHI AB (publ) annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 janvier 2024	CI
14/03	Phase Holographic Imaging PHI AB (Publ) nomme Ivan Jurkovic membre ordinaire du conseil d'administration	CI

PHI partners with University College London to use HoloMonitor in a first clinical research project	09:33	AQ
PHI terminates agreement regarding liquidity provider	04/06	AQ
PHI to BioStock: "It's the right moment to capitalize on regenerative medicine momentum."	23/05	AQ
PHI secures a loan facility of in total SEK 7 million	17/05	AQ
PHI announces conference schedule for spring 2024	02/04	AQ
Interim Report 3 2023/24	27/03	AQ
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)	14/03	AQ
Shaping the future of Regenerative Medicine - PHI's vision for QPI in Cell Therapy Manufacturing	11/03	AQ
New Distributor Partner Manager at Altium set to enhance global sales for PHI	05/03	AQ
Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB	26/02	AQ
PHI to BioStock: "We aim to revolutionize the regenerative medicine market "	21/02	AQ
PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024	07/02	AQ
PHI announces extraordinary quarter sales of about 5MSEK - marks the highest ever in Company history	30/01	AQ
Interim Report 2 2023/24	21/12	AQ
PHI appoints Pareto Securities AB to act as a liquidity provider for the Company's share	15/12	AQ
PHI granted patent on synthetic antibodies in the EU	07/12	AQ
Directed issue registered at the Companies Registration Office	23/11	AQ
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)	15/11	AQ
BioStock: PHI's CEO reflects on the Company's momentum	14/11	AQ
BioStock: Altium fuels PHI's forward drive	09/11	AQ

Aucun résultat pour cette recherche